Amyloid Biomarkers in Conformational Diseases at Face Value: A Systematic Review

Aβ propagation and strains: Implications for the phenotypic diversity in Alzheimer's disease

(2018) Carlo Condello et al.   NEUROBIOLOGY OF DISEASE

Investigating the effects of erythrosine B on amyloid fibril formation derived from lysozyme

(2017) Chun-Tien Kuo et al.   INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES

Polyphenols protect mitochondrial membrane against permeabilization induced by HEWL oligomers: Possible mechanism of action

(2017) Shaqayeq Roqanian et al.   INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES

Modulation effect of acidulated human serum albumin on Cu 2+ -mediated amyloid β-protein aggregation and cytotoxicity under a mildly acidic condition

(2017) Baolong Xie et al.   JOURNAL OF INORGANIC BIOCHEMISTRY

Bridging Type 2 Diabetes and Alzheimer's Disease: Assembling the Puzzle Pieces in the Quest for the Molecules With Therapeutic and Preventive Potential

(2017) Ana Marta de Matos et al.   MEDICINAL RESEARCH REVIEWS

PTI-125 binds and reverses an altered conformation of filamin A to reduce Alzheimer's disease pathogenesis

(2017) Hoau-Yan Wang et al.   NEUROBIOLOGY OF AGING

Trehalose induced conformational changes in the amyloid-β peptide

(2017) Shagufta H. Khan et al.   PATHOLOGY RESEARCH AND PRACTICE

Novel insight into streptozotocin-induced diabetic rats from the protein misfolding perspective

(2017) Edgar Leyva-García et al.   Scientific Reports

Technical performance of a novel, fully automated electrochemiluminescence immunoassay for the quantitation of β-amyloid (1–42) in human cerebrospinal fluid

(2016) Tobias Bittner et al.   Alzheimers & Dementia

Structural differences between amyloid beta oligomers

(2016) Leonid Breydo et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Crystal Structures of IAPP Amyloidogenic Segments Reveal a Novel Packing Motif of Out-of-Register Beta Sheets

(2016) Angela B. Soriaga et al.   JOURNAL OF PHYSICAL CHEMISTRY B

The activities of amyloids from a structural perspective

(2016) Roland Riek et al.   NATURE

Peripherally administered sera antibodies recognizing amyloid-β oligomers mitigate Alzheimer's disease-like pathology and cognitive decline in aged 3× Tg-AD mice

(2016) Hai-Chao Wang et al.   VACCINE

The Role of Amyloid-β Oligomers in Toxicity, Propagation, and Immunotherapy

(2016) Urmi Sengupta et al.   EBioMedicine

Clinical utility of cerebrospinal fluid biomarkers in the diagnosis of early Alzheimer's disease

(2015) Kaj Blennow et al.   Alzheimers & Dementia

Platelet dysfunction in hypercholesterolemia mice, two Alzheimer’s disease mouse models and in human patients with Alzheimer’s disease

(2015) Barbara Plagg et al.   BIOGERONTOLOGY

High affinity binding of conformationally constrained synthetic oligomers to an antigen-specific antibody: Discovery of a diagnostically useful synthetic ligand for murine Type 1 diabetes autoantibodies

(2015) Todd M. Doran et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

Oligomers, protofibrils and amyloid fibrils from recombinant human lysozyme (rHL): Fibrillation process and cytotoxicity evaluation for ARPE-19 cell line

(2015) Eva D. Ruiz et al.   COLLOIDS AND SURFACES B-BIOINTERFACES

Isobaric Quantification of Cerebrospinal Fluid Amyloid-β Peptides in Alzheimer’s Disease: C-Terminal Truncation Relates to Early Measures of Neurodegeneration

(2015) Magnus Rogeberg et al.   JOURNAL OF PROTEOME RESEARCH

Drug Development in Conformational Diseases: A Novel Family of Chemical Chaperones that Bind and Stabilise Several Polymorphic Amyloid Structures

(2015) Marquiza Sablón-Carrazana et al.   PLoS One

An improved method for high-level soluble expression and purification of recombinant amyloid-beta peptide for in vitro studies

(2015) Gaurav Chhetri et al.   PROTEIN EXPRESSION AND PURIFICATION

Structure based aggregation studies reveal the presence of helix-rich intermediate during α-Synuclein aggregation

(2015) Dhiman Ghosh et al.   Scientific Reports

The Prevalence of Compassion Fatigue and Burnout among Healthcare Professionals in Intensive Care Units: A Systematic Review

(2015) Margo M. C. van Mol et al.   PLoS One

Detection and quantification of plasma amyloid-β by selected reaction monitoring mass spectrometry

(2014) Jun Seok Kim et al.   ANALYTICA CHIMICA ACTA

Conformation-specific antibodies to target amyloid β oligomers and their application to immunotherapy for Alzheimer’s disease

(2014) Kazuma Murakami   BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY

Gallic acid, one of the components in many plant tissues, is a potential inhibitor for insulin amyloid fibril formation

(2014) Jayaraman Jayamani et al.   EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

Trichostatin A increases the levels of plasma gelsolin and amyloid beta-protein in a transgenic mouse model of Alzheimer's disease

(2014) Wenzhong Yang et al.   LIFE SCIENCES

Detection of Misfolded Aβ Oligomers for Sensitive Biochemical Diagnosis of Alzheimer’s Disease

(2014) Natalia Salvadores et al.   Cell Reports

New ELISAs with high specificity for soluble oligomers of amyloid β-protein detect natural Aβ oligomers in human brain but not CSF

(2013) Ting Yang et al.   Alzheimers & Dementia

CSF biomarker variability in the Alzheimer's Association quality control program

(2013) Niklas Mattsson et al.   Alzheimers & Dementia

The inhibitory effects of Escherichia coli maltose binding protein on β-amyloid aggregation and cytotoxicity

(2013) Md. Golam Sharoar et al.   ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS

Enzyme-Linked Immunosorbent Assay-Based Method to Quantify the Association of Small Molecules with Aggregated Amyloid Peptides

(2012) Christina C. Capule et al.   ANALYTICAL CHEMISTRY

Pittsburgh compound B and the postmortem diagnosis of alzheimer disease

(2012) Dana M. Niedowicz et al.   ANNALS OF NEUROLOGY

The Amyloid State of Proteins in Human Diseases

(2012) David Eisenberg et al.   CELL

Hyperamylinemia Contributes to Cardiac Dysfunction in Obesity and Diabetes

(2012) Sanda Despa et al.   CIRCULATION RESEARCH

Amyloid β-sheet mimics that antagonize protein aggregation and reduce amyloid toxicity

(2012) Pin-Nan Cheng et al.   Nature Chemistry

ELISA measurement of specific non-antigen-bound antibodies to Aβ1-42 monomer and soluble oligomers in sera from Alzheimer's disease, mild cognitively impaired, and noncognitively impaired subjects

(2011) Andrea C Klaver et al.   Journal of Neuroinflammation

Conformation dependent monoclonal antibodies distinguish different replicating strains or conformers of prefibrillar Aβ oligomers

(2011) Rakez Kayed et al.   Molecular Neurodegeneration

α-Mangostin, a polyphenolic xanthone derivative from mangosteen, attenuates β-amyloid oligomers-induced neurotoxicity by inhibiting amyloid aggregation

(2011) Yan Wang et al.   NEUROPHARMACOLOGY

Alzheimer's Disease

(2010) Henry W. Querfurth et al.   NEW ENGLAND JOURNAL OF MEDICINE

Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects

(2009) Leslie M. Shaw et al.   ANNALS OF NEUROLOGY

Protein folding and binding: moving into unchartered territory

(2009) Valerie Daggett et al.   CURRENT OPINION IN STRUCTURAL BIOLOGY

CSF Biomarkers and Incipient Alzheimer Disease in Patients With Mild Cognitive Impairment

(2009) Niklas Mattsson   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration

(2009) Alessandro Liberati et al.   PLOS MEDICINE

Amyloid formation by globular proteins under native conditions

(2008) Fabrizio Chiti et al.   Nature Chemical Biology

Biochemical markers in persons with preclinical familial Alzheimer disease

(2008) J. M. Ringman et al.   NEUROLOGY

Amyloid oligomers in diabetic and nondiabetic human pancreas

(2008) Hai-Lu Zhao et al.   Translational Research

Prediction and longitudinal study of CSF biomarkers in mild cognitive impairment

(2007) Miroslaw Brys et al.   NEUROBIOLOGY OF AGING